KCI Expands Surgical Incision Management Offering in Europe
KCI, an Acelity Company, today announced the availability of two additional PREVENA™ Therapy offerings in Europe: the PREVENA DUO™ Incision Management System with PEEL & PLACE™ Dressing - 13cm and PREVENA PLUS PEEL & PLACE™ Incision Management System – 35cm. Both of the new introductions incorporate the proven clinical benefits of PREVENA™ Therapy, providing clinicians with solutions to meet the evolving needs of post-surgical incision management. PREVENA™ Therapy helps hold incision edges together and protects incisions from external infectious sources.
The PREVENA DUO™ System is the first single use negative pressure wound therapy (NPWT) system designed specifically for the simultaneous management of two closed surgical incisions, configured to help reduce post-operative complications in bilateral procedures, such as vascular harvesting, breast reconstruction and orthopedic trauma surgeries.
PREVENA PLUS PEEL & PLACE™ System – 35cm is suitable for long incisions commonly used in revision surgery, while also providing higher exudate storage capacity. The PREVENA PLUS™ System offers the proven effectiveness of negative pressure wound therapy with improved versatility, portability, and flexibility.
“Surgical site infections are an issue plaguing heath systems, clinicians and patients around the world,” said R. Andrew Eckert, Chief Executive Officer, KCI. “The ever-growing body of evidence supporting PREVENA™ Therapy continues to demonstrate its efficacy in lowering the incidence of SSIs. In line with our unwavering commitment to patients and our goal of moving healing forward, we hope that as a result of the availability of these two new products, more European patients will be able to benefit from PREVENA™ Therapy and reduce the burden of SSIs.”
“The impact surgical site infections have on patients its significant - delaying their recovery and return to work, causing financial worry and affecting their mental health,” Ron Silverman, M.D., FACS, Chief Medical Officer, KCI. “For those patients who are at increased risk of post-operative complications we need to look carefully at their care to ensure that they recover quickly and effectively. We are proud to be able to introduce the PREVENA DUO™ System and PREVENA PLUS PEEL & PLACE™ System – 35cm in Europe, helping provide clinicians with the tools needed to best serve their patients and provide quality care.”
Surgical site infections (SSIs) present a significant burden in Europe, with more than 500,000 cases in Europe each year.1 SSIs are associated with longer post-operative hospital stays, reduced patient quality of life, may necessitate additional surgical procedures, may require intensive care, and can result in higher morbidity and mortality.2 Infections, the most common surgical site complication, account for up to 20 percent of all of healthcare-associated infections and cost the NHS up to £700 million each year.3,4
Recently, the National Institute for Health and Care Excellence (NICE) published a Medtech Innovation Briefing (MIB) on PREVENA™ Incision Management System. The MIB assesses the most recent published evidence on the technology and surmises that PREVENA™ Therapy can lead to significantly reduced incision site complications in comparison to standard care dressings. Clinical specialists invited to add comment in the report also agreed that using PREVENA™ Therapy would likely lead to cost savings as a result of the reduction in surgical site complications (SSCs) and a reduced need for dressing changes.5
About PREVENA™ Incision Management System
The PREVENA™ System, launched in 2010, is the first disposable negative pressure system designed specifically for the management of closed surgical incisions. The PREVENA™ Incision Management System protects the incision from external contamination, helps hold incision edges together, removes fluid and infection materials, and delivers continuous negative pressure at -125mmHg for up to seven days.
Please refer to the PREVENA™ Incision Management System instructions for use for important limitations and safety information.
About KCI, an Acelity Company
KCI, an Acelity Company, is a well trusted brand in advanced wound care. We are a leader in negative pressure wound therapy, providing solutions for both wound healing and surgical management. Our product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing. Headquartered in San Antonio, Texas, KCI employs approximately 4,500 people worldwide.
2 Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank H-P, Ducomble T, et al. (2016) Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLoS Med 13(10): e1002150. https://doi.org/10.1371/journal.pmed.1002150
3 National Institute for Health and Care Excellence. Clinical guideline CG74. Surgical site infections: prevention and treatment. April 2019. Available at: https://www.nice.org.uk/guidance/ng125. Accessed July 15, 2019.
4 Leaper DJ, van Goor H, Reilly J et al. Surgical site infection - a European perspective of incidence and economic burden. Int Wound J 2004; 1: 247–735. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-4801.2004.00067.x
5 National Institute for Health and Care Excellence. Prevena incision management system for closed surgical incisions. Medtech innovation briefing. 28 February 2019. Available at: https://www.nice.org.uk/advice/mib173. Accessed July 15, 2019.
Phone: +1 (210) 255-6433
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
European Commission Approves Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible20.1.2020 21:43:00 EET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) has granted marketing authorisation for Darzalex® (daratumumab) in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant (ASCT). This approval is based on results from Part one of the Phase 3 CASSIOPEIA (MMY3006) study, published in The Lancet 5 in June 2019 and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting. “The effectiveness of first-line treatment is critical to maximise time until relapse. So, we asked ourselves, can we improve the standard of care that is bortezomib, thalidomide and dexamethasone (VTd) to provide patients with valuable extra time?” said Philippe Moreau, M.D., principal investigator and Head of the Haematology Department at the University Hospital of Nantes, France. “The CASSIOPEIA study answered that
Citi Private Bank Hails Fernando Alonso on His Impressive Maiden Dakar Rally20.1.2020 20:00:00 EET | Press release
Citi Private Bank-sponsored motorsports legend, Fernando Alonso, has electrified his fans with his debut performance in one of the toughest motorsports-endurance events, the Dakar Rally. The multiple world champion finished fourth in the race’s final stage, and was the leading newcomer overall. This marked an impressive comeback from the difficulties he experienced earlier in the week, when his car suffered wheel and suspension damage, as well as a later double-roll crash. The annual Dakar Rally – now in its forty-second year – is an extreme off-road endurance race. This year’s edition consisted of twelve daily stages covering a total of 7,500 kilometers (4,600 miles). As well as a contest between some of the world’s top drivers, the Dakar Rally pits drivers against grueling terrains. In 2020, drivers faced the additional challenge of receiving information about the course on the mornings of certain legs of the race, rather than the day before. “Fernando’s tenacious performance in his
Keio Plaza Hotel Tokyo Hosts “Hina-Matsuri” Girls’ Doll Festival Art Exhibition20.1.2020 17:05:00 EET | Press release
Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will host an event entitled “Hina-Matsuri Girls’ Doll Festival Art Exhibition” to help guests celebrate Japan’s cultural event known as Girls’ Doll Festival or Hina-Matsuri from February 1 to March 26, 2020. This highly popular event is held annually and displays some 6,800 magnificent and ornate hanging art ornaments made by hand from old silk cloth. These ornaments are carefully crafted for this exhibition and symbolically reflect the hopes for health and happiness of children. Also, peach flowers are featured as a theme for exhibition, concerts and workshops in this year’s event in keeping with the “Peach Festival” and the belief that peaches lead to longevity as they drive off evil spirits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200120005118/en/ About 6,800 hanging ornaments, each one handmade from kimon
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask20.1.2020 17:00:00 EET | Press release
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200120005042/en/ AirFit F30i tube-up full face mask, front view (Photo: Business Wire) Full face CPAP users can now choose between a tube-up or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam versus silicone cushion. AirFit F30i’s tube-up design makes it easier to sleep in any position. The cushion rests under the nose to help prevent next-day red marks, soreness, and irritation on the nasal bridge. Plus, a quick-release elbow allows users to quickly disconnect and reattach the mask from its tubing at night without taking the mask off. Three out of four CPAP users prefer AirFit F30i to its competitor’s tube-up full face mask for overall performance i
xx network Announces Support of Early Backers of xx coin Sale20.1.2020 17:00:00 EET | Press release
The xx network has announced support of crypto pioneers, including Chris Larsen, for the initial Cayman sale of the xx coin starting on January 23, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200120005068/en/ xx network photo (Photo: Business Wire) The xx coin is a quantum secure digital currency designed to support and incentivize the decentralized ecosystem of the xx network, the revolutionary privacy-protecting blockchain led by David Chaum, founder of the Elixxir and Praxxis projects which underpin the xx network. Chris Larsen, a serial entrepreneur, co-founder of the Ripple Network and longtime advocate for consumer privacy, said, "David Chaum has been a defender of privacy in the digital world for almost forty years. I am proud to be an early backer and look forward to seeing this consumer-facing blockchain open the door to secure use by millions of individuals in their daily lives." Ownership and control of t
Wipro Positioned as a Leader in Networks - Software Defined Solutions and Services for UK and Nordics20.1.2020 16:56:00 EET | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has been positioned as a Leader in ISG Provider Lens™: Network - Software Defined Solutions and Services quadrant report for Nordics and the U.K. The reports were authored by Avimanyu Basu. ISG recognized Wipro after evaluating the capabilities of 153 providers across seven quadrants: Managed WAN Services; Mobile Network (4G/5G) Additional (non-core) Services; SDN Transformation Services (Consulting and Implementation); SD-WAN Equipment and Services (DIY); SDN Security Services; SD Network Technologies (Core), and SD Network Technologies (Mobile to Edge). Wipro has been named a ‘Leader’ in Managed WAN Services, SDN Transformation Services (Consulting & Implementation), SDN security services, SD Network Technologies (Core) and SD Network Technologies (Mobile to Edge) quadrant in the ISG Provider Lens™: Network - Software D
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom